In colorectal cancer (CRC), SETD2 has been shown to regulate the Wnt signaling pathway in engineered mouse models (GEMs), and SETD2 loss promoted tumor progression (Yuan et al., 2017). The gene discussed is SETD2; the disease is colorectal carcinoma.